We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Vor Biopharma
VOR
$1.06B
| $1.86M | ﹤0.01% |
17,304
+2,329
| +16% | +$258K |
|
877
Nutanix
NTNX
$16.1B
| $1.86M | ﹤0.01% |
71,500
+4,050
| +6% | +$110K |
|
878
Franco-Nevada
FNV
$41.3B
| $1.85M | ﹤0.01% |
12,723
+2,400
| +23% | +$335K |
|
879
SouthState Bank Corp
SSB
$10.3B
| $1.85M | ﹤0.01% |
25,900
+650
| +3% | +$50.6K |
|
880
Teladoc Health
TDOC
$1.66B
| $1.85M | ﹤0.01% |
71,260
-200
| -0.3% | -$5.35K |
|
881
Prime Medicine
PRME
$547M
| $1.84M | ﹤0.01% |
150,000
| – | – |
|
882
Invesco
IVZ
$12.4B
| $1.84M | ﹤0.01% |
111,980
+16,600
| +17% | +$296K |
|
883
Jefferies Financial Group
JEF
$12.7B
| $1.83M | ﹤0.01% |
57,550
-80,444
| -58% | -$2.91M |
|
884
MasTec
MTZ
$22.7B
| $1.82M | ﹤0.01% |
19,310
+2,250
| +13% | +$214K |
|
885
Cullen/Frost Bankers
CFR
$10.5B
| $1.82M | ﹤0.01% |
17,269
+750
| +5% | +$93.4K |
|
886
Timken Company
TKR
$9.19B
| $1.81M | ﹤0.01% |
22,094
-490
| -2% | -$39.6K |
|
887
Doximity
DOCS
$3.89B
| $1.8M | ﹤0.01% |
55,469
+4,342
| +8% | +$144K |
|
888
Silicon Laboratories
SLAB
$7.14B
| $1.79M | ﹤0.01% |
10,244
+1,150
| +13% | +$193K |
|
889
Wingstop
WING
$3.8B
| $1.79M | ﹤0.01% |
9,760
+250
| +3% | +$41K |
|
890
NovoCure
NVCR
$1.76B
| $1.77M | ﹤0.01% |
29,490
+650
| +2% | +$51.9K |
|
891
TechnipFMC
FTI
$28.6B
| $1.76M | ﹤0.01% |
129,290
| – | – |
|
892
Murphy Oil
MUR
$5.55B
| $1.76M | ﹤0.01% |
47,525
+2,250
| +5% | +$89.8K |
|
893
Prosperity Bancshares
PB
$8.9B
| $1.76M | ﹤0.01% |
28,536
-11,246
| -28% | -$801K |
|
|
WBA
894
DELISTED
Walgreens Boots Alliance
WBA
| $1.75M | ﹤0.01% |
50,624
-29,672
| -37% | -$1.05M |
|
895
Novanta
NOVT
$4.91B
| $1.75M | ﹤0.01% |
10,990
+600
| +6% | +$92.1K |
|
896
GXO Logistics
GXO
$5.93B
| $1.75M | ﹤0.01% |
34,620
+2,350
| +7% | +$117K |
|
897
Landstar System
LSTR
$6.03B
| $1.74M | ﹤0.01% |
9,731
+750
| +8% | +$132K |
|
898
Realty Income
O
$61.1B
| $1.74M | ﹤0.01% |
27,478
+6,855
| +33% | +$444K |
|
899
Oshkosh
OSK
$8.91B
| $1.74M | ﹤0.01% |
20,900
+2,050
| +11% | +$186K |
|
900
Newell Brands
NWL
$2.21B
| $1.73M | ﹤0.01% |
139,014
+20,350
| +17% | +$287K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.